BriaCell Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de BriaCell Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BCTX | BriaCell Therapeutics | -$33.00 | -$3.28 | — | — | $0.00 | $2.10M | — | — | 12/15/2025 | |
BCTX | BriaCell Therapeutics | -$10.50 | -$3.28 | -$4.81 | -46.65% | $0.00 | $2.10M | $0.00 | -100.00% | 10/16/2025 | |
BCTX | BriaCell Therapeutics | $16.50 | — | -$16.40 | — | $0.00 | — | $0.00 | — | 06/16/2025 | |
BCTX | BriaCell Therapeutics | -$106.50 | — | -$23.30 | — | $0.00 | — | $0.00 | — | 03/12/2025 | |
BCTX | BriaCell Therapeutics | -$75.00 | -$45.00 | -$33.00 | 26.67% | $0.00 | — | $0.00 | — | 12/16/2024 | |
BCTX | BriaCell Therapeutics | -$22.50 | -$78.00 | -$10.50 | 86.54% | $0.00 | — | $0.00 | — | 10/29/2024 | |
BCTX | BriaCell Therapeutics | -$48.00 | -$82.50 | $16.50 | 120.00% | $0.00 | — | $0.00 | — | 06/14/2024 | |
BCTX | BriaCell Therapeutics | -$115.50 | -$30.00 | -$106.50 | -255.00% | $0.00 | — | $0.00 | — | 03/18/2024 | |
BCTX | BriaCell Therapeutics | -$10.50 | — | -$75.00 | — | $0.00 | — | $0.00 | — | 12/14/2023 | |
BCTX | BriaCell Therapeutics | -$151.50 | — | -$22.50 | — | $0.00 | — | $0.00 | — | 10/25/2023 | |
BCTX | BriaCell Therapeutics | -$97.50 | -$70.50 | -$48.00 | 31.91% | $0.00 | — | $0.00 | — | 06/14/2023 | |
BCTX | BriaCell Therapeutics | -$36.00 | -$55.50 | -$115.50 | -108.11% | $0.00 | — | $0.00 | — | 03/16/2023 | |
BCTX | BriaCell Therapeutics | -$24.00 | -$49.50 | -$10.50 | 78.79% | $0.00 | — | $0.00 | — | 12/14/2022 | |
BCTX | BriaCell Therapeutics | — | -$52.50 | -$151.50 | -188.57% | — | — | $0.00 | — | 10/28/2022 | |
BCTX | BriaCell Therapeutics | $94.50 | -$25.50 | -$48.00 | -88.24% | $0.00 | — | $0.00 | — | 06/13/2022 | |
BCTX | BriaCell Therapeutics | -$78.00 | — | -$36.00 | — | $0.00 | — | $0.00 | — | 03/15/2022 | |
BCTX | BriaCell Therapeutics | — | — | -$24.00 | — | — | — | $0.00 | — | 12/15/2021 | |
BCTX | BriaCell Therapeutics | -$846.00 | — | -$13.50 | — | $0.00 | — | $0.00 | — | 11/01/2021 | |
BCTX | BriaCell Therapeutics | -$391.50 | — | -$78.00 | — | — | — | $0.00 | — | 04/01/2021 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2025-10-16 | $-4.81 | $-3.28 | -46.7 % |
| Q1 | 2024-12-16 | $-33.00 | $-45.00 | 26.7 % |
| Q4 | 2024-10-29 | $-10.50 | $-78.00 | 86.5 % |
| Q3 | 2024-06-14 | $16.50 | $-82.50 | 120.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2025-10-16 | $0 | $2.10M | -100.0 % |
Está previsto que BriaCell Therapeutics (BCTX) presente resultados el diciembre 15, 2025. Los últimos resultados se publicaron el octubre 16, 2025 para el Q4.
El BPA real fue de $-4.81, que no alcanzó la estimación de $-3.28.
Los ingresos reales fueron $0K, que no alcanzó la estimación de $2.1M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.